Related Experiment Video
Updated: Jun 25, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
The complexities of T-cell dysfunction in chronic lymphocytic leukemia
Elena Camerini1, Derk Amsen2, Arnon P Kater3
1Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands; Department of Hematology, Amsterdam UMC, Amsterdam, The Netherlands.
Chronic lymphocytic leukemia (CLL) impairs T-cell function, hindering T-cell therapies. This review explores T-cell defects in CLL and strategies to restore T-cell function for improved treatment outcomes.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy with significant T-cell dysfunction.
- T-cell-based therapies effective in other B-cell cancers show limited success in CLL.
- The precise mechanisms of T-cell dysfunction in CLL remain poorly understood.
Purpose of the Study:
- To review T-cell support signals in the CLL lymph node microenvironment.
- To summarize T-cell functional defects observed in CLL patients.
- To explore potential causes and novel strategies for reversing T-cell dysfunction in CLL.
Main Methods:
- Literature review of T-cell interactions in the CLL niche.
- Analysis of T-cell functional defects in chronic lymphocytic leukemia.
- Exploration of therapeutic strategies targeting T-cell dysfunction.
Main Results:
- T cells provide supporting signals to CLL cells within the lymph node niche.
- Key findings on T-cell functional impairments in CLL are summarized.
- Potential causes for T-cell dysfunction are discussed, alongside emerging therapeutic avenues.
Conclusions:
- Understanding T-cell dysfunction in CLL is crucial for developing effective treatments.
- Strategies to reverse CLL-induced T-cell defects may enhance autologous T-cell therapies.
- Restoring T-cell function holds promise for improving therapeutic outcomes in CLL patients.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

